Propofol infusion syndrome: Case report and literature review

American Journal of Health-System Pharmacy

Volumn 66, Issue 10, 2009, Pages 908-915

  Orsini, Jose ^a   Nadkarni, Abhijeet ^c   Chen, Julie ^a   Cohen, Nina ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NONE

Author keywords

Anesthetics; Antiinfective agents; Anxiolytics, sedatives and hypnotics; Dosage; Injections; Midazolam; Phenobarbital; Propofol; Respiratory insufficiency; Sepsis; Steroids, cortico ; Toxicity; Vasoconstricting agents

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; CREATINE KINASE; FENTANYL; HYDROCORTISONE; HYPERTENSIVE FACTOR; MICAFUNGIN; MIDAZOLAM; MOXIFLOXACIN; NORADRENALIN; PHENOBARBITAL; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VANCOMYCIN; VASOPRESSIN;

ADULT; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FATTY LIVER; FEMALE; HEPATOMEGALY; HISPANIC; HUMAN; INTENSIVE CARE UNIT; INTUBATION; LABORATORY TEST; LOADING DRUG DOSE; MAINTENANCE THERAPY; MEASLES LIKE RASH; PNEUMONIA; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; RESPIRATORY FAILURE; SEDATION; SEPSIS; SIDE EFFECT; SINUS TACHYCARDIA; SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WEANING;

EID: 65649136586     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070605     Document Type: Article

References (46)

1. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth. 1998; 8:491-499 (Pubitemid 28523410)
2. Parke TJ, Stevens JE Rice AS et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ. 1992; 305:613-616
3. Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology. 2000; 92:727-738 (Pubitemid 30130176)
4. Diprivan 1% (propofol) injectable emulsion package insert. Wilmington, DE: AstraZeneca Pharmaceuticals LP; 2005.
5. Fulton B, Sorkin EM. Propofol: an overview of its pharmacology and a review of its clinical efficacy in the intensive care sedation. Drugs. 1995; 50:636-657
6. Koch M, De Baker D, Vincent JL. Lactic acidosis: an early marker of propofol infusion syndrome? Intensive Care Med. 2004; 30:522. Letter. (Pubitemid 38375635)
7. Salengros JC, Engelman E. Myoglobulinemia and propofol infusion. Acta Anesthesiol Scand. 2006; 50:125-126 Letter.
8. Salengros JC, Velghe-Lenelle CE, Bollens R et al. Lactic acidosis during propofolremifentanyl anesthesia in an adult. Anesthesiology. 2004; 101:241-243 (Pubitemid 38833287)
9. Wolf A, Weir P, Segar P et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001; 357:606-607 (Pubitemid 32179617)
10. Valente JF, Anderson GL, Branson RD et al. Disadvantages of prolonged propofol sedation in the critical care unit. Crit Care Med. 1994;22:710-712 (Pubitemid 24121575)
11. Vasile B, Rasulo F, Candiani A et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003; 29:1417-1425 (Pubitemid 37153585)
12. Culp KE, Augoustides JG, Ochroch AE et al. Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg. 2004; 99:221-226 (Pubitemid 38808194)
13. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med. 2000; 28:3071-3074
14. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985; 17:291-306. (Pubitemid 15030720)
15. Sabsovich I, Rehman Z, Yunen J et al. Propofol infusion syndrome: a case of increasing morbidity with traumatic brain injury. Am J Crit Care. 2007; 16:82-85
16. Stelow EB, Johari VP, Smith SA et al. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. Clin Chem. 2000; 46:577-581 (Pubitemid 30210736)
17. Vernooy K, Delhaas T, Cremer OL et al. Electrocardiographic changes predicting death in propofol-related infusion syndrome. Heart Rhythm. 2006; 3:131-137 (Pubitemid 43149982)
18. Cremer OL, Moons KG, Bouman EA et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001; 357:117-118 (Pubitemid 32094917)
19. Brussel T, Theissen JL, Vigfusson G et al. Hemodynamic and cardiodynamic effects of propofol and etomidate: negative inotropic properties of propofol. Anesth Analg. 1989; 69:35-40. (Pubitemid 20037061)
20. Kumar MA, Urrutia VC, Thomas CE et al. The syndrome of irreversible acidosis after prolonged propofol infusion. Neurocrit Care. 2005; 3:257-259 (Pubitemid 43004823)
21. Martin P, Di Bisceglie AM, Kassianides C et al. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 1989; 97:1559-1561 (Pubitemid 20004186)
22. Martinez-Sierra C, Arizcorreta A, Díaz F et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis. 2003; 36:491-498 (Pubitemid 36241318)
23. Soto B, Sánchez-Quijano A, Rodrigo L et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol. 1997; 26:1-5. (Pubitemid 27072597)
24. Kumar AN, Schwartz DE, Lim KG. Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge. Chest. 1999; 115:1198-1199 (Pubitemid 29193699)
25. Redfern N, Stafford MA, Hull CJ. Incremental propofol for short procedures. Br J Anaesth. 1985; 57:1178-1182
26. Badr AE, Mychaskiw G 2nd, Eichhorn JH. Metabolic acidosis associated with a new formulation of propofol. Anesthesiology. 2001; 94:536-538
27. Burow BK, lohnson ME, Packer DL. Metabolic acidosis associated with propofol in the absence of other causative factors. Anesthesiology. 2004; 101:239-241
28. Casserly B, O'Mahony E, Timm EG et al. Propofol infusion syndrome: an unusual cause of renal failure. Am J Kidney Dis. 2004; 44:e98-101. (Pubitemid 39556471)
29. Chukwuemeka A, Ko R, Ralph-Edwards A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intensive Care. 2006; 34:651-655 (Pubitemid 44687836)
30. Corbett SM, Moore J, Rebuck JA et al. Survival of propofol infusion syndrome in a head-injured patient. Crit Care Med. 2006; 34:2479-2483 (Pubitemid 44260035)
31. De Waele JJ, Hoste E. Propofol infusion syndrome in a patient with sepsis. Anaesth Intensive Care. 2006; 34:676-677 (Pubitemid 44687842)
32. Ernest D, French C. Propofol infusion syndrome - report of an adult fatality. Anaesth Intensive Care. 2003; 31:316-319 (Pubitemid 36805959)
33. Friedman JA, Manno E, Fulgham JR. Propofol. J Neurosurg. 2002; 96:1161-1162 Letter.
34. Hanna JP, Ramundo ML. Rhabdomyolysis and hypoxia associated with prolonged infusion in children. Neurology. 1998; 50:301-303 (Pubitemid 28106063)
35. Karakitsos D, Poularas J, Kalogeromitros A et al. The propofol infusion syndrome treated with haemofiltration. Is there a time for genetic screening? Acta Anaesthesiol Scand. 2007; 51:644-645 Letter. (Pubitemid 46570031)
36. Kelly DF. Propofol-infusion syndrome. J Neurosurg. 2001; 95:925-926 Editorial. (Pubitemid 33123846)
37. Liolios A, Guerit JM, Scholtes JL et al. Propofol infusion syndrome associated with short-term large-dose infusion during surgical anesthesia in an adult. Anesth Analg. 2005; 100:1804-1806 (Pubitemid 40712743)
38. Machata AM, Gonano C, Biisan T et al. Rare but dangerous adverse effects of propofol and thiopental in intensive care. J Trauma. 2005; 58:643-645 (Pubitemid 40365834)
39. Marinella MA. Lactic acidoses associated with propofol. Chest. 1996; 109:292. Letter.
40. Merz TM, Regli B, Rothen HU et al. Propofol infusion syndrome - a fatal case at a low infusion rate. Anesth Analg. 2006; 103:1050. Letter. (Pubitemid 44576741)
41. Rosen DJ, Nicoara A, Koshy N et al. Too much of a good thing? Tracing the history of the propofol infusion syndrome. J Trauma. 2007; 63:443-447 (Pubitemid 47254674)
42. Zaronaya EL, Jobst BC, Harris BT. Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus. Epilepsia. 200; 48:1002-1006 (Pubitemid 46763414)
43. Cravens GT, Packer DL, Johnson ME. Incidence of propofol infusion syndrome during noninvasive radiofrequency ablation for atrial flutter or fibrillation. Anesthesiology. 2007; 106:1134-1138 (Pubitemid 46828166)
44. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245 (Pubitemid 11140804)
45. Kane-Gill SL, Kirisci L, Pathak DS. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit? Ann Pharmacother. 2005; 39:1823-1827 (Pubitemid 41527694)
46. Kane-Gill SL, Devlin JW. Adverse drug event reporting in intensive care units: a survey of current practices. Ann Pharmacother. 2006; 40:1267-1273 (Pubitemid 44204955)